Esthel Ronco
17 Papers
122 Citations
Esthel Ronco is an academic researcher. The author has contributed to research in topics: Biology & Plasmid. The author has an hindex of 11, co-authored 17 publications.
Chat about Author
Papers
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
TL;DR: The properties of a novel extended-spectrum beta-lactamase in P. aeruginosa which may not be derived by point mutations from previously known enzymes of this species are reported.
230
Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes.
Laurent Poirel,Thierry Lambert,Salih Turkoglu,Esthel Ronco,Jean-Louis Gaillard,Patrice Nordmann +5 more
TL;DR: Two clonally unrelated Pseudomonas aeruginosa clinical strains were isolated in 1997 and 1998 from patients hospitalized in a suburb of Paris, France, and expressed the class B carbapenem-hydrolyzing β-lactamase VIM-2 previously identified in Marseilles in the French Riviera.
184
Identification of clinical coagulase‐negative staphylococci, isolated in microbiology laboratories, by matrix‐assisted laser desorption/ionization‐time of flight mass spectrometry and two automated systems
Christian Dupont,Valérie Sivadon-Tardy,Emmanuelle Bille,Emmanuelle Bille,B. Dauphin,Jean-Luc Beretti,Anne-Sophie Alvarez,Nicolas Degand,Agnès Ferroni,Martin Rottman,Jean-Louis Herrmann,Xavier Nassif,Xavier Nassif,Esthel Ronco,Etienne Carbonnelle,Etienne Carbonnelle +15 more
TL;DR: The present study demonstrates the robustness and high sensitivity of the microbial identification database used with MALDI-TOF-MS technology and represents a powerful tool for the fast ID of clinical CoNS isolates.
137
An SHV-Derived Extended-Spectrum β-Lactamase in Pseudomonas aeruginosa
TL;DR: A clinical isolate of Pseudomonas aeruginosa RP-1 produced the extended-spectrum β-lactamase (ESBL) SHV-2a, which was expressed from a composite promoter made of the −35 region derived from the left inverted repeat of IS26 and the −10 region from the blaSHV- 2a promoter itself.
136
Intermediate Mutation Frequencies Favor Evolution of Multidrug Resistance in Escherichia coli
Erick Denamur,Olivier Tenaillon,Catherine Deschamps,David Skurnik,Esthel Ronco,Jean Louis Gaillard,Bertrand Picard,Catherine Branger,Ivan Matic +8 more
TL;DR: It is observed that modest modifications of mutation frequency may significantly influence the evolution of antibiotic resistance among Escherichia coli natural isolates.
61